(function(){var loadHandler=window['sl_{C6DEFA30-7612-4C19-8C71-E1939E05EB9B}'];loadHandler&&loadHandler(7, '<div id="spr0_1215759"><div id="spr1_1215759" class="kern"><img id="img3_1215759" src="data/img5.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/><div id="svg3_1215759" style="top:-1.309px;"><svg width="720" height="80" viewBox="0 0 720 80"><path fill="#034396" d="M0,0 h720 v79.854 h-720 Z"/></svg></div><div id="svg4_1215759" style="left:19.334px;top:519.166px;"><svg width="27" height="13" viewBox="0 0 27 13"><path fill="#e6eaee" d="M0,0 h26.182 v12.908 h-26.182 Z"/></svg></div><div id="spr3_1215759" style="left:28px;top:522px;"><img id="img0_1215759" src="data/img2.png" width="9" height="6" alt="8"/></div></div><div id="spr2_1215759" class="kern"><div id="svg5_1215759" style="left:32.984px;top:106.685px;"><svg width="643" height="396" viewBox="-0.375 -0.375 643 396"><path fill="none" stroke="#41719c" stroke-opacity="0" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.375,0.375 h640.75 v394 h-640.75 Z"/></svg></div><div id="spr4_1215759" style="left:83.415px;top:10.52px;"><img id="img1_1215759" src="data/img22.png" width="493" height="456" alt="" style="left:-0.207px;top:0.226px;"/></div><div id="svg6_1215759" style="left:81.165px;top:151.574px;"><svg width="75" height="5" viewBox="-2.25 -1.125 75 5"><g fill="#ff0000" stroke="none"><path stroke="#ff0000" stroke-width="2.25" stroke-linecap="butt" transform="translate(-83.414719,-152.699173)" d="M83.415,153.824 H153.904"/></g></svg></div><div id="svg9_1215759" style="left:331.293px;top:197.014px;"><svg width="68" height="44" viewBox="-0.75 -0.75 68 44"><ellipse fill="none" stroke="#ff0000" stroke-width="1.5" stroke-linecap="butt" stroke-linejoin="round" stroke-dasharray="6,4.5" cx="32.868" cy="20.807" rx="32.118" ry="20.057"/></svg></div><div id="svg10_1215759" style="left:32.597px;top:469.496px;"><svg width="665" height="56" viewBox="-0.375 -0.375 665 56"><path fill="none" stroke="#41719c" stroke-opacity="0" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.375,0.375 h663.128 v54.325 h-663.128 Z"/></svg></div><div id="spr5_1215759" style="left:42px;top:479px;"><img id="img2_1215759" src="data/img23.png" width="608" height="42" alt="There was a substantial difference regarding the types of adverse events\
Pancreatitis rate was lower with EUS-BD approach compared to ERCP \
"/></div></div></div>');})();